To investigate this hypothesis, we initially assessed the HIF-2α mRNA levels in bladder cancer cells and observed minimal fluctuations in HIF-2α levels irrespective of the RON expression levels in cancer cells (Fig. 4B). The gene discussed is MST1R; the disease is urinary bladder cancer.